Acute necrotizing esophagitis (ANE) is a severe form of acute esophagitis that ap− pears dark black in color ("black esopha− gus") at endoscopy due to mucosal necro− sis [1] . ANE is an uncommon condition of unknown etiology. Grudell et al. reported that among 52 cases of ANE, seven cases involved massive gastroesophageal reflux [2] . As gastroesophageal reflux is one of the proposed causes of ANE [3, 4] , treat− ment generally includes administration of a proton pump inhibitor (PPI). A 67−year−old man complained of vomit− ing and chest pain 5 days after surgery for a vitreous hemorrhage. The patient had a history of diabetes mellitus, hyperten− sion, hyperlipidaemia, and angina pec− toris. Endoscopy revealed a black−appear− ing esophageal mucosa extending from the proximal two thirds of the esophagus to the cardia (l " Fig. 1 ). After 6 days of treatment that included oral nutritional rest for 1 week and rabeplazole (20 mg/ day), the mucosal surface was diffusely covered with whitish exudates (l " Fig. 2) , and biopsy specimens consisted of necro− tic debris. By continuing to take rabepla− zole for 4 months after release from hos− pital, the patient was cured of esophagitis (l " Fig. 3 ). However, 37 days after finish− ing the rabeplazole treatment, the patient returned due to recurring vomiting and chest pain. Endoscopy revealed a reoccur− rence of the black−appearing esophageal mucosa and whitish exudates, as well as mucosal bleeding (l " Fig. 4 ). Upon rees− tablishment of the treatment described previously, the relapsed ANE improved considerably within 3 weeks. With con− tinued administration of rabeplazole, the ANE has not relapsed.
To our knowledge, this is the first report− ed case of a relapse of ANE [2, 5] A relapse case of acute necrotizing esophagitis Fig. 1 Endoscopy revealed a black−appearing esophageal mucosa extending from the proxi− mal two thirds of the esophagus to the cardia. Fig. 2 After 6 days of treatment, the esopha− geal surface was diffusely covered with whitish exudates. Fig. 3 By continuing to take rabeplazole for 4 months after release from hospital, the patient was cured of esophagitis. Fig. 4 The patient returned 37 days after fin− ishing the rabeplazole treatment, and endos− copy revealed a reoccurrence of the black−ap− pearing esophageal mucosa and whitish exu− dates, as well as mucosal bleeding. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
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